NCT02200991 Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine Status COMPLETED Phase PHASE4
NCT02193191 Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT02187848 Evaluation of SAR408701 in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT02181101 Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial Status COMPLETED Phase PHASE3
NCT02179970 To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers Status COMPLETED Phase PHASE1
NCT02173990 Aflibercept and Chemotherapy as First Line Treatment for Metastatic Colorectal Cancer Assessable With DCE-US (PULSAR). Status TERMINATED Phase PHASE2
NCT02169817 Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American Children Status COMPLETED Phase PHASE4
NCT02166658 A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet) Status TERMINATED Phase PHASE2
NCT02157116 Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT02134028 Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) Status COMPLETED Phase PHASE3
NCT02129257 Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT02124031 Mexican Initiative of Patients With Osteoarthritis and Rheumatoid Arthritis (IMPACTAR) Status COMPLETED Phase N/A
NCT02121210 To Evaluate the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE3
NCT02115165 A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors Status COMPLETED Phase PHASE2
NCT02107898 Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN) Status COMPLETED Phase PHASE3
NCT02097524 Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE1
NCT02085005 Capecitabine Plus Aflibercept as Maintenance Therapy Following Capecitabine Plus Oxaliplatin Plus Aflibercept in Patients With Metastatic Colorectal Cancer Status WITHDRAWN Phase PHASE2